Financhill
Back

LiqTech International Vs. Keros Therapeutics Industry Stock Comparison

Buy
65

LIQT
LiqTech International

Last Price:
2.33
Seasonality Move:
10.89%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.37
Seasonality Move:
4.22%
Buy
65
LiqTech International (LIQT) is a Buy

Is LiqTech International a Buy, Sell or Hold?

  • The current LiqTech International [LIQT] share price is $2.27. The Score for LIQT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • LIQT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIQT Stock Price Chart

What is LiqTech International's stock price today?

  • The LiqTech International share price today is $2.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIQT is experiencing slight buying pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

LIQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 42.33 Sell
Chaikin Money Flow: 40405 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.25 - 2.71) Sell
Bollinger Bands (100): (2.53 - 3.17) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

LIQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.2 Buy
20-day SMA: 2.43 Sell
50-day SMA: 2.58 Sell
200-day SMA: 3.23 Sell
8-day EMA: 2.2 Buy
20-day EMA: 2.37 Sell
50-day EMA: 2.57 Sell
200-day EMA: 3.22 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

LiqTech International Earnings Growth & LIQT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.16 per share, a decrease this year of $0.35 per share, and an increase next year of $0.82 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

LiqTech International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):